Home » Stocks » Vaso Corporation

Vaso Corporation (VASO)

Stock Price: $0.0238 USD 0.0040 (19.00%)
Updated Oct 20, 2020 3:02 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 4.16M
Revenue (ttm) 76.30M
Net Income (ttm) 1.67M
Shares Out 174.72M
EPS (ttm) 0.01
PE Ratio 2.38
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 20, 2020
Last Price $0.0238
Previous Close $0.0200
Change ($) 0.0040
Change (%) 19.00%
Day's Open 0.0200
Day's Range 0.0200 - 0.0240
Day's Volume 39,561
52-Week Range 0.01 - 0.04

More Stats

Market Cap 4.16M
Enterprise Value 11.09M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 174.72M
Float 97.00M
EPS (basic) 0.01
EPS (diluted) 0.01
FCF / Share 0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield 42.02%
FCF Yield 99.56%
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 2.28
PE Ratio 2.38
Forward PE n/a
P/FCF Ratio 1.00
PS Ratio 0.05
PB Ratio 0.88
Revenue 76.30M
Operating Income 2.40M
Net Income 1.67M
Free Cash Flow 4.14M
Net Cash -6.93M
Net Cash / Share -0.04
Gross Margin 55.91%
Operating Margin 3.15%
Profit Margin 2.20%
FCF Margin 5.43%
ROA 3.27%
ROE 54.38%
ROIC 43.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue75.7573.9872.7972.5957.0834.9532.8929.2416.374.21
Revenue Growth2.39%1.64%0.27%27.17%63.31%6.28%12.48%78.59%289.28%-
Gross Profit42.6641.1240.7341.5035.3725.1922.5120.5910.912.21
Operating Income1.01-3.72-3.831.563.941.06-1.29-3.51-3.93-1.98
Net Income0.04-3.73-4.540.823.821.13-1.15-3.38-3.89-1.89
Shares Outstanding168165162159157155159158112102
Earnings Per Share--0.02-0.030.010.020.01-0.01-0.02-0.04-0.02
EPS Growth----50%100%-----
Operating Cash Flow-1.33-1.451.605.226.522.59-1.509.434.14-1.59
Capital Expenditures-1.18-2.59-2.37-1.87-0.89-0.37-0.23-0.40-0.14-0.03
Free Cash Flow-2.52-4.04-0.783.355.632.23-1.739.034.00-1.61
Cash & Equivalents2.122.675.257.092.169.248.0711.588.240.55
Total Debt13.5510.538.859.837.330.16---1.25
Net Cash / Debt-11.43-7.86-3.61-2.74-5.179.088.0711.588.24-0.70
Assets54.3650.4756.7857.3850.4240.9933.5232.3818.553.86
Liabilities48.5844.8647.6344.4738.6833.2427.0523.3715.653.43
Book Value5.795.619.1512.9111.747.756.479.012.910.43
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Vaso Corporation
Country United States
Employees 294
CEO Jun Ma

Stock Information

Ticker Symbol VASO
Stock Exchange US OTC
Sector Healthcare
Industry Health Information Services
Unique Identifier OTCMKTS: VASO
IPO Date October 24, 1988

Description

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging capital equipment, GEHC service agreements, and GEHC and third party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment provides Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for physiological signals, such as ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsaion therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease, as well as in-service training support. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. The company was founded in 1987 and is headquartered in Plainview, New York.